- Recent Funding
- Investors
- Novalis LifeSciences
Novalis LifeSciences portfolio
Novalis LifeSciences has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Ori Biotech's $100M Series B+ round in January 2022, which it led, alongside Puhua Capital, Octopus Ventures, Northpond Ventures and 3 others. That company is in Health and bio.
What Novalis LifeSciences invests in
- Health and bio · 1 · 100%
- Manufacturing and industrial · 1 · 100%
How Novalis LifeSciences invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $100M |
Share is of the 1 round on Recent Funding that name Novalis LifeSciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Novalis LifeSciences portfolio companies
OOri Biotech$100MSeries B+ · Jan 2022
| Company | Round with Novalis LifeSciences | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $100M · lead | $100M | Jan 18, 2022 Series B+ |
Most frequent co-investors
OOctopus Ventures1 shared round · last Jan 18, 2022
AAmadeus Capital Partners1 shared round · last Jan 18, 2022
CChimera Investment1 shared round · last Jan 18, 2022
NNorthpond Ventures1 shared round · last Jan 18, 2022
PPuhua Capital1 shared round · last Jan 18, 2022
DDelin Ventures1 shared round · last Jan 18, 2022
Similar investors
AAccelia Capital1 company · 1 deal in 12 mo
BBioGenerator Ventures1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moFFirst Imagine!1 company · 1 deal in 12 mo
MMaxis1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Novalis LifeSciences, which is a subset of its real portfolio. API: /api/v1/investors/novalis-lifesciences (get a free API key). More: the most active VC firms and new venture capital funds.